2023-504879-24-00已完成4 期
In vivo bioequivalence study of a new clobetasol propionate 0.05% topical cream compared to DERMOVAL® 0.05% cream using the skin blanching bioassay in healthy subjects.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Substipharm
- 入组人数
- 102
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Florence TRESPEUCH
Scientific
Substipharm
研究点 (1)
Loading locations...
相似试验
招募中
1 期
In vivo bioequivalence study of a new clobetasol propionate 0.05% topical cream compared to DERMOVAL® 0.05% cream using the skin blanching bioassay in healthy subjects.corticosteroid-sensitive dermatosisCTIS2023-504879-24-00Substipharm102
尚未招募
1 期
Bioequivalence of ClopidogrelHealthy volunteersHealthy VolunteersRPCEC00000257Center for Pharmaceutical Research and Development, Havana, Cuba.24
已完成
不适用
Comparison of efficacy of topical clobetasol 0.05% plus 5FU 5% cream vs. topical clobetasol 0.05% alone in the treatment of vitiligo.Vitiligo.vitiligoIRCT201203049198N2Isfahan Univercity of Medical Sciences45
进行中（未招募）
1 期
Clinical study to assess the efficacy of Clobetasol mouth rinses in patientswith oral lichen planus.MedDRA version: 20.1Level: PTClassification code 10030983Term: Oral lichen planusSystem Organ Class: 10017947 - Gastrointestinal disordersOral lichen planusEUCTR2018-004222-28-SEMalmö University90
招募中
不适用
In-vivo Bioequivalence study of Clopidegrel tablet with brand drugs (PLAVIX SANOFI, USA)IRCT20200105046010N35SanaMed Co.24